Novel potential metabolic biomarker panel for early detection of severe COVID-19 using full-spectrum metabolome and whole-transcriptome analyses
Signal Transduct Target Ther
.
2022 Apr 22;7(1):129.
doi: 10.1038/s41392-022-00976-2.
Authors
Zhi-Bin Li
#
1
2
3
4
5
,
Jun Liu
#
2
,
Shan-Qiang Zhang
#
2
,
Yi Yu
1
2
4
5
,
Hong-Feng Liang
1
,
Qi-Qi Lu
2
,
Jing Chen
1
2
4
5
,
Yu-Shuai Han
1
2
4
5
,
Fan Zhang
2
,
Ji-Cheng Li
6
7
8
9
Affiliations
1
The Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China.
2
Medical Research Center, Yue Bei People's Hospital, Shantou University Medical College, 512025, Shaoguan, China.
3
Medical School, Hubei Minzu University, 445000, Enshi, China.
4
Department of Histology and Embryology, Shaoguan University School of Medicine, 512025, Shaoguan, China.
5
Institute of Cell Biology, Zhejiang University School of Medicine, 310058, Hangzhou, China.
6
The Central Laboratory, Yangjiang People's Hospital, 529500, Yangjiang, China. lijichen@zju.edu.cn.
7
Medical Research Center, Yue Bei People's Hospital, Shantou University Medical College, 512025, Shaoguan, China. lijichen@zju.edu.cn.
8
Department of Histology and Embryology, Shaoguan University School of Medicine, 512025, Shaoguan, China. lijichen@zju.edu.cn.
9
Institute of Cell Biology, Zhejiang University School of Medicine, 310058, Hangzhou, China. lijichen@zju.edu.cn.
#
Contributed equally.
PMID:
35459913
PMCID:
PMC9026054
DOI:
10.1038/s41392-022-00976-2
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
MeSH terms
Biomarkers
COVID-19* / diagnosis
COVID-19* / genetics
Gene Expression Profiling
Humans
Metabolome / genetics
Substances
Biomarkers